Treatment during a Developmental Window Prevents NF1-Associated Optic Pathway Gliomas by Targeting Erk-Dependent Migrating Glial Progenitors

Scientists provided the proof-of-concept evidence for preventing pediatric low-grade gliomas before tumor-associated neurological damage entered an irreversible phase.